| Literature DB >> 30395587 |
Cheng-Yang Hsieh1,2, Chin-Wei Huang3, Darren Philbert Wu4, Sheng-Feng Sung4,5.
Abstract
OBJECTIVE: Stroke is a well-known and devastating complication during the perioperative period. However, detailed stroke risk profiles within 90 days in patients discharged without stroke after inpatient surgery are not fully understood. Using the case-crossover design, we aimed to evaluate the risk of ischemic stroke in these patients.Entities:
Mesh:
Year: 2018 PMID: 30395587 PMCID: PMC6218083 DOI: 10.1371/journal.pone.0206990
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Schematic illustration of the study design.
Comorbidities were ascertained using the claims within 365 days while medications were obtained from the claims within 90 days. Three risk time periods (1 to 30, 31 to 60, and 61 to 90 days) were evaluated.
Comorbidities and medication use before incident hospitalization for ischemic stroke.
| Case period | Control period | ||
|---|---|---|---|
| 55.0 | 51.0 | <0.001 | |
| 30.6 | 28.8 | <0.001 | |
| 19.0 | 18.1 | <0.001 | |
| 5.1 | 4.0 | <0.001 | |
| 16.3 | 15.0 | <0.001 | |
| 9.0 | 7.1 | <0.001 | |
| 4.9 | 3.7 | <0.001 | |
| 9.5 | 8.6 | <0.001 | |
| 3.4 | 2.9 | <0.001 | |
| 2.2 | 1.7 | <0.001 | |
| 5.4 | 4.4 | <0.001 | |
| 2 (0–4) | 1 (0–3) | <0.001 | |
| 33.9 | 29.5 | <0.001 | |
| 24.4 | 21.5 | <0.001 | |
| 33.9 | 31.9 | <0.001 | |
| 16.3 | 14.2 | <0.001 | |
| 6.2 | 5.5 | <0.001 | |
| 25.3 | 24.0 | <0.001 | |
| 5.4 | 4.4 | <0.001 | |
| 15.5 | 14.3 | <0.001 | |
| 27.1 | 24.6 | <0.001 | |
| 2.1 | 1.8 | <0.001 | |
| 38.8 | 35.8 | <0.001 | |
| 6.7 | 4.8 | <0.001 |
ACE, angiotensin-converting enzyme; ARB, angiotensin receptor blocker; IQR, interquartile range; NSAID, nonsteroidal anti-inflammatory drug.
Surgery performed during the case and control periods.
| Case period | Control period | |||||
|---|---|---|---|---|---|---|
| 1–30 d | 31–60 d | 61–90 d | 1–30 d | 31–60 d | 61–90 d | |
| 20 (2.0) | 15 (2.0) | 11 (1.7) | 15 (2.6) | 8 (1.4) | 3 (0.6) | |
| 25 (2.4) | 15 (2.0) | 16 (2.5) | 17 (2.9) | 21 (3.7) | 8 (1.5) | |
| 17 (1.7) | 14 (1.8) | 17 (2.6) | 19 (3.3) | 12 (2.1) | 12 (2.3) | |
| 209 (20.4) | 136 (17.7) | 127 (19.4) | 79 (13.6) | 83 (14.7) | 85 (16.4) | |
| 91 (8.9) | 92 (12.0) | 67 (10.3) | 45 (7.7) | 51 (9.1) | 43 (8.3) | |
| 295 (28.8) | 226 (29.4) | 174 (26.6) | 140 (24.1) | 149 (26.5) | 154 (29.7) | |
| 81 (7.9) | 55 (7.2) | 52 (8.0) | 60 (10.3) | 40 (7.1) | 42 (8.1) | |
| 10 (1.0) | 8 (1.0) | 5 (0.8) | 7 (1.2) | 9 (1.6) | 7 (1.4) | |
| 196 (19.2) | 159 (20.7) | 135 (20.7) | 152 (26.1) | 161 (28.6) | 129 (24.9) | |
| 67 (6.6) | 42 (5.5) | 47 (7.2) | 43 (7.4) | 22 (3.9) | 31 (6.0) | |
| 12 (1.2) | 6 (0.8) | 2 (0.3) | 5 (0.9) | 7 (1.2) | 4 (0.8) | |
| 1023 (100) | 768 (100) | 653 (100) | 582 (100) | 563 (100) | 518 (100) | |
Data are numbers (percentage).
Risk of ischemic stroke associated with surgery (n = 56596).
| Surgery | No. of patients undergoing surgery during case period | No. of patients undergoing surgery during control period | Crude OR (95% CI) | Adjusted OR | Adjusted OR |
|---|---|---|---|---|---|
| 1023 | 582 | 1.79 (1.62–1.99) | 1.41 (1.26–1.57) | 1.44 (1.29–1.61) | |
| 768 | 563 | 1.38 (1.24–1.55) | 1.03 (0.91–1.16) | 1.05 (0.93–1.18) | |
| 653 | 518 | 1.27 (1.13–1.43) | 0.98 (0.87–1.11) | 1.00 (0.88–1.13) |
OR, odds ratio; CI, confidence interval.
aAdjusted for discordance of comorbidities, health care utilization, and use of medications.
bAdjusted for discordance of comorbidities, health care utilization, use of medications, and mode of anesthesia.
Fig 2Risk of ischemic stroke across various types of surgery.
Adjusted odds ratios and 95% confidence intervals for various types of surgery associated with ischemic stroke within 1–30, 31–60, and 61–90 days using case-crossover analysis (A) and case-time-control analysis (B). Adjustment was made for discordance of comorbidities, health care utilization, use of medications, and mode of anesthesia.
Risk of ischemic stroke associated with surgery using case-time-control analyses (n = 54384).
| Case-crossover | Case-time-control | |||||
|---|---|---|---|---|---|---|
| Surgery | Crude OR (95% CI) | Adjusted OR | Adjusted OR | Crude OR (95% CI) | Adjusted OR | Adjusted OR |
| 1.76 (1.58–1.95) | 1.38 (1.24–1.55) | 1.42 (1.27–1.58) | 1.17 (1.03–1.34) | 1.02 (0.89–1.17) | 1.04 (0.91–1.20) | |
| 1.50 (1.27–1.78) | 1.38 (1.16–1.64) | 1.37 (1.15–1.63) | ||||
| 1.35 (1.20–1.51) | 1.00 (0.89–1.13) | 1.02 (0.91–1.15) | 1.10 (0.96–1.26) | 0.94 (0.82–1.08) | 0.96 (0.84–1.11) | |
| 1.22 (1.02–1.46) | 1.09 (0.90–1.30) | 1.08 (0.90–1.30) | ||||
| 1.28 (1.14–1.44) | 0.99 (0.88–1.12) | 1.01 (0.89–1.15) | 1.04 (0.91–1.20) | 0.91 (0.79–1.04) | 0.92 (0.80–1.06) | |
| 1.23 (1.02–1.47) | 1.12 (0.93–1.35) | 1.11 (0.93–1.34) | ||||
OR, odds ratio; CI, confidence interval.
aAdjusted for discordance of comorbidities, health care utilization, and use of medications.
bAdjusted for discordance of comorbidities, health care utilization, use of medications, and mode of anesthesia.
cG = 1 for cases with stroke and G = 0 for controls.